ENZON PHARMACEUTICALS, INC. Quarterly Income Tax Expense (Benefit) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Enzon Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2010 to Q3 2024.
  • Enzon Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $49K, a 35.5% decline year-over-year.
  • Enzon Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$195K, a 85.7% decline year-over-year.
  • Enzon Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was -$156K, a 22% increase from 2022.
  • Enzon Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was -$200K, a 2957% decline from 2021.
  • Enzon Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $7K, unchanged from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$195K $49K -$27K -35.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 -$168K $4K -$48K -92.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$120K $1K +$36K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$156K -$249K -$51K -25.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-20
Q3 2023 -$105K $76K +$74K +3700% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 -$179K $52K +$52K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$231K -$35K -$31K -775% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$200K -$198K -$203K -4060% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-20
Q3 2022 $3K $2K +$2K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $1K $0 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $1K -$4K -$6K -300% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $7K $5K $0 0% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-16
Q3 2021 $7K $0 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $7K $0 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $7K $2K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-26
Q4 2020 $7K $5K +$1K +25% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-25
Q3 2020 $6K $0 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $6K $0 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $6K $2K $0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $6K $4K $0 0% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-23
Q3 2019 $6K $0 -$1K -100% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $7K $0 $0 Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 $7K $2K +$1K +100% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q4 2018 $6K $4K +$803K Oct 1, 2018 Dec 31, 2018 10-K 2020-02-19
Q3 2018 -$797K $1K +$338K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$1.14M $0 -$2.25M -100% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $1.12M $1K -$445K -99.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $1.56M -$799K -$6.07M -115% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-21
Q3 2017 $7.63M -$337K -$1.01M -150% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $8.64M $2.25M +$1.45M +181% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 $7.19M $446K -$582K -56.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $7.77M $5.27M +$15.4M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-21
Q3 2016 -$7.62M $674K -$214K -24.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$7.41M $801K -$93K -10.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 -$7.31M $1.03M +$3.52M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$10.8M -$10.1M -$10.1M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-24
Q3 2015 -$713K $888K +$887K +88700% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$1.6M $894K +$894K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 -$2.49M -$2.5M -$2.55M -4636% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $56K $0 $0 Oct 1, 2014 Dec 31, 2014 10-K 2016-03-21
Q3 2014 $56K $1K +$242K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 -$186K $0 -$80K -100% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$106K $55K -$78K -58.6% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 -$28K $0 +$4.17M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-05
Q3 2013 -$4.2M -$241K -$241K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 -$3.96M $80K +$47K +142% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 -$4M $133K +$133K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 -$4.14M -$4.17M -$4.17M Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 $33K $0 -$200K -100% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $233K $33K +$28K +560% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $205K $0 $0 Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 $205K $0 Oct 1, 2011 Dec 31, 2011 10-K 2014-03-14
Q3 2011 $200K +$331K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $5K +$210K Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-08-21
Q1 2011 $0 Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-02
Q3 2010 -$131K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 -$205K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.